FRIDAY, May 28, 2021 (HealthDay News) — Many health experts hailed the recent approval of the Pfizer vaccine for those aged 12 to 15, but some parents have been hesitant to take their kids in for a shot. “Parents naturally worry more about their children than they do about themselvesContinue Reading

FRIDAY, May 28, 2021 (HealthDay News) — About 1 in 10 U.S. cancer survivors delays follow-up care because they can’t afford associated medical bills, even if they’re insured. That’s the conclusion from an analysis of data from more than 5,400 survivors of various cancers. Most were insured, college-educated and hadContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — A third antibody treatment designed to keep high-risk COVID-19 patients from winding up in the hospital was approved for emergency use by the U.S. Food and Drug Administration on Wednesday. Importantly, in lab tests the newly authorized drug, dubbed sotrovimab, neutralized the highlyContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer’s disease research, two new studies show. The findings are from an analysis of national data by Jeffrey Cummings, a research professor at the University of Nevada, Las VegasContinue Reading

TUESDAY, May 25, 2021 (HealthDay News) — Comedian and commentator Bill Maher recently made news of his own when he contracted COVID-19 despite being fully vaccinated. But such breakthrough COVID-19 cases among the vaccinated are rare, according to new data from the U.S. Centers for Disease Control and Prevention’s COVID-19Continue Reading

TUESDAY, May 25, 2021 (HealthDay News) — The virus fueling the COVID-19 pandemic could become just an ordinary sniffle-causing nuisance within the next 10 years, a new study suggests. Researchers stressed that the projection is based on mathematical models, and not a crystal-ball prediction. But, they say, given what’s knownContinue Reading

TUESDAY, May 25, 2021 (HealthDay News) — Moderna’s coronavirus vaccine fully protects children aged 12 to 17, the company announced Tuesday. In a clinical trial that included more than 3,700 young volunteers, there were no cases of symptomatic COVID-19 infection in the two-thirds of participants who received both doses ofContinue Reading